Summit Wealth Group (Colorado)’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,947
Closed -$91.2K 415
2025
Q3
$91.2K Buy
+10,947
New +$727K 0.01% 481

Other funds holding HALO

Summit Wealth Group (Colorado)'s HALO Position: Q4 2025 in Review

Summit Wealth Group (Colorado) sold out of Halozyme (HALO) in Q4 2025, closing a stake of 10,947 shares — an estimated $91.2K sold.

Summit Wealth Group (Colorado) first reported a position in HALO in Q3 2025 and held it in 1 quarter. The position peaked at $91.2K in Q3 2025. 618 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Summit Wealth Group (Colorado) reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Summit Wealth Group (Colorado) sold 10,947 Halozyme shares in Q4 2025, an estimated $91.2K.
  • Summit Wealth Group (Colorado) first reported a position in Halozyme in Q3 2025 and held it in 1 quarter.
  • Summit Wealth Group (Colorado)'s Halozyme position peaked at $91.2K in Q3 2025.
  • 618 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Summit Wealth Group (Colorado)'s 13F filing for Q4 2025, filed 4 Feb 2026.